Abstract
A fluorometric study has been carried out, for the first time, to investigate the reaction of the new generation antidepressant sertraline (SRT) with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). In an alkaline buffered medium (pH 8.0), a green fluorescent product exhibiting maximum fluorescence intensity at 532 nm after excitation at 470 nm was produced. The factors affecting the reaction were carefully studied and the conditions were optimized. The kinetics of the reaction was investigated, the stoichiometry of the reaction was determined, and the mechanism was postulated. The activation energy of the reaction was determined and found to be 27.34 KJ mole-1. Under the optimum reaction conditions, a linear relationship with good correlation coefficient (r = 0.9998, n = 6) was found between the fluorescence intensity of the reaction product and SRT concentrations in the range of 0.3–20.0 µg ml-1. The limit of detection and limit of quantitation were 0.07 and 0.21 µg ml-1, respectively. The intra- and inter-assay precisions were satisfactory; the relative standard deviations did not exceed 2.61%. The proposed method was successfully applied to the determination of SRT in its pharmaceutical tablets with good accuracy; the recovery percentages were 96.97–102.23 ± 1.01–1.62%. The results were compared favorably with those of the reported method.
Similar content being viewed by others
References
Pigott TA, Seay SM (1999) A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 60:101–106
Muijsers RB, Plosker GL, Noble S (2002) Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 19:377–392
Eap CB, Baumann P (1996) Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients. J Chromatogr B Biomed Appl 686:51–63
Onal A, Kepekci SE, Cetin M, Erturk S (2006) Spectrophotometric determination of certain antidepressants in pharmaceutical preparations. J AOAC Intl 89:966–971
Darwish IA, Refaat IH (2006) Spectrophotometric analysis of selective serotonin reuptake inhibitors based on formation of charge-transfer complexes with tetracyano-quinodimethane and chloranilic acid. J AOAC Intl 89:326–333
Darwish IA (2005) Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. J AOAC Intl 88:38–45
Erk N (2003) Rapid and simple methods for quantitative analysis of some antidepressant in pharmaceutical formulations by using first derivative spectrophotometry and HPLC. Farmaco 58:1209–1216
Aktas E, Erturk S (2003) Determination of sertraline by ion-pair extraction with methyl orange. Acta Pharmaceutica Tur 45:51–54
Hassen EM (2001) Spectrophotometric analysis of sertraline by derivative spectro-photometry and charge transfer complexation. Bull Fac Pharm (Cairo University) 39:353–359
El Kousy NM, Bebawy LI, Suddik JK, Shokry GM (1999) Determination of fluoxetine hydrochloride and sertraline hydrochloride using acid dyes. Egy J Pharm Sci 39:323–336
Bebawy LI, El Kousy NM, Suddik JK, Shokry GM (1999) Spectrophotometric determination of fluoxetine and sertraline using chloranil, 2, 3 dichloro-5, 6-dicyanobenzoquinone and iodine. J Pharm Biomed Anal 21:133–142
Musenga A, Kenndler E, Mercolini L, Amore M, Fanali S, Raggi MA (2007) Determination of sertraline and N-desmethylsertraline in human plasma by CE with LIF detection. Electrophoresis 28:1823–1831
Himmelsbach M, Buchberger W, Klampfl CW (2006) Determination of antidepressants in surface and waste water samples by capillary electrophoresis with electrospray ionization mass spectrometric detection after preconcentration using off-line solid-phase extraction. Electrophoresis 27:1220–1226
Nouws HPA, Delerue-Matos C, Barros AA, Rodrigues JA (2005) Electroanalytical study of the antidepressant sertraline. J Pharm Biomed Anal 39:290–293
Lacassie E, Gaulier JM, Marquet P, Rabatel JF, Lachatre G (2000) Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. J Chromatogr B 742:229–238
Wille SM, Van Hee P, Neels HM, Van Peteghem CH, Lambert WE (2007) Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma. J Chromatogr A 1176:236–245
Kim KM, Jung BH, Choi MH, Woo JS, Paeng KJ, Chung BC (2002) Rapid and sensitive determination of sertraline in human plasma using gas chromatography-mass spectrometry. J Chromatogr B 769:333–339
Mandrioli R, Saracino MA, Ferrari S, Berardi D, Kenndler E, Raggi MA (2006) HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 836:116–119
Silva BJ, Lanças FM, Queiroz ME (2008) In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 862:181–188
Jain DS, Sanyal M, Subbaiah G, Pande UC, Shrivastav P (2005) J Chromatogr B Analyt Technol Biomed Life Sci 829:69–74
de Castro A, Concheiro M, Quintela O, Cruz A, López-Rivadulla M (2008) LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma Study of correlation between venlafaxine concentrations in both matrices. J Pharm Biomed Anal 48:183–193
Lucca A, Gentilini G, Lopez-Silva S, Soldarini A (2000) Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Ther Drug Monit 22:271–276
Ulu ST (2006) Highly sensitive spectrofluorimetric determination of ephedrine hydrochloride in pharmaceutical preparations. J AOAC Intl 89:1263–1267
El-Emam AA, Hansen SH, Moustafa MA, Ashry SM, Sherbiny DT (2004) Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection. J Pharm Biomed Anal 34:35–44
Darwish IA, Mahmoud AM, Khalil NY (2008) Non-extractive procedure and pre-column derivatization with 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole for trace determination of trimetazidine in plasma by HPLC with fluorescence detection. J AOAC Intl 91:1037–1044
Aktas ES, Ersoy L, Sagirh O (2003) A new spectrofluorimetric method for the determination of lisinopril in tablets. Il Farmaco 58:165–168
Imai K, Toyo Oka T, Miyano H (1984) Fluorigenic reagents for primary and secondary amines and thiols in high-performance liquid chromatography: a review. Analyst 109:1365–1373
Rose J (1964) Advanced physico-chemical experiments. Pitman, London, p 67
Darwish IA (2005) Kinetic spectrophotometric methods for determination of trimetazidine dihydrochloride. Anal Chim Acta 551:222–231
Martin AN, Swarbrick J, Cammarata A (1983) Physical Pharmacy, 3rd edn. Lee and Febiger, Philadelphia, pp 371–374 344–346
ICH guideline, Q2(R1) (2005) Validation of analytical procedures: text and methodology. London.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahmoud, A.M., Darwish, I.A. & Khalil, N.Y. Fluorometric Study for the Reaction Between Sertraline and 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: Kinetics, Mechanism and Application for the Determination of Sertraline in Tablets. J Fluoresc 20, 607–613 (2010). https://doi.org/10.1007/s10895-009-0595-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10895-009-0595-3